Zakład Produkcyjny Firmy Servier w Polsce, Anpharm

About Zakład Produkcyjny Firmy Servier w Polsce, Anpharm

We are one of 16 Manufacturing Site of the Servier Group, and at the same time one of the first original innovator companies manufacturing drugs in Poland. Using modern technologies and operating in an environment of strict quality requirements, we are aware that delivering medicines of the highest quality to our patients and the safety of our employees is our mission. More than 27 years we have experience in the manufacture medicines for the Polish market and also for export. Our portfolio contains a range of finished and semi-finished products. Today, almost all of the Servier Group’s products sold in Poland are produced by our site. 50% of the products manufactured by us are destined for export to 26 European markets. The consistent, significant financial investment of Servier Group and the transfer of modern technology enabled the dynamic development of our manufacturing site. Over 27 years we have increased our production volume from 4 million to nearly more than 51 million packages every year, gradually increasing the employment (from 60 to over 280 in 2024). Every day we produce 5 million tablets of the highest quality. Annually, it amounts to 1 billion 200 million tablets. We were the first drug-producing manufacture in Poland to receive GMP Certificate - Good Manufacture Practice (in 2003 - license then renewed every 3 years) and one of the first pharmaceutical companies in Poland which granted ISO 50001 certificate for energy management system (Certificate granted in 2016). REPORT A SIDE EFFECT If you think you may have a health problem related to a Servier product or any other Servier health product, you can contact us at any time and report it to us at: https://servier.pl/zglaszanie-dzialan-niepozadanych/

View contact profiles from Zakład Produkcyjny Firmy Servier w Polsce, Anpharm